NoIR 11% Dark Gray SpectraShield Small 422-31
by NoIR
Last verified June 19, 2026 · classified April 26, 2026
What it is
Summary
AI-generated from vendor-published content · April 26, 2026
These are specialized low-vision sunglasses with dark gray tinted lenses that transmit only 11% of visible light, designed to reduce glare and improve contrast for people with light-sensitive eyes. They're built for someone with conditions like albinism, aniridia, cataracts, macular degeneration, or photophobia who struggles with bright sunlight or harsh indoor lighting. The SpectraShield frame includes a top ledge brow bar and side shields to block stray light from all angles — not just what comes through the lenses — and they fit over prescription glasses, so no separate pair is needed. At this transmission level, they're quite dark, which is ideal for bright outdoor conditions but may feel too dim in low-light environments.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
- Vocational rehab
What Setup Looks Like
- Out of the box
- Put on the sunglasses — wear alone or slide over existing prescription glasses.
- The side shields and top ledge are built in; no adjustment needed for full protection.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
As an Amazon Associate we earn from qualifying purchases.
How to Fund This
Equipment like this is often pursued through official state programs. These are common starting points — each program decides its own eligibility and what it covers, so the first step is always a phone call.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from NoIR — view on vendor site; last verified June 19, 2026.
Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.